CASI Pharmaceuticals (CASI)
NASDAQ:CASI
US Market
Holding CASI?
Track your performance easily

CASI Pharmaceuticals (CASI) Financial Statements

444 Followers

CASI Pharmaceuticals Financial Overview

CASI Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.02; its P/E ratio is -2.71; CASI Pharmaceuticals is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $-0.62. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue-$ 15.26M$ 10.21M$ 8.57M$ 9.06M
Gross Profit-$ 10.99M$ 5.97M$ 5.02M$ 5.30M
EBIT-$ -16.52M$ -5.01M$ -7.53M$ -8.47M
EBITDA-$ -15.63M$ -4.25M$ -7.20M$ -8.04M
Net Income Common Stockholders-$ -19.54M$ -5.20M$ -7.68M$ -8.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.77M$ 49.88M$ 33.05M$ 24.61M$ 37.52M
Total Assets$ 75.27M$ 96.23M$ 127.91M$ 118.86M$ 129.56M
Total Debt$ 18.89M$ 0.00$ 3.92M$ 2.04M$ 0.00
Net Debt$ -11.87M$ -49.88M$ -29.13M$ -22.57M$ -37.52M
Total Liabilities$ 51.10M$ 29.30M$ 44.69M$ 29.25M$ 54.58M
Stockholders Equity$ 24.16M$ 44.53M$ 61.71M$ 66.94M$ 74.99M
Cash Flow-
Free Cash Flow-$ -4.27M$ -6.99M$ -8.78M$ -6.53M
Operating Cash Flow--$ -6.52M$ -9.48M$ -4.24M
Investing Cash Flow--$ 16.45M$ -961.00K$ -2.29M
Financing Cash Flow--$ 2.00M$ 1.00M$ -3.00M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

CASI Pharmaceuticals Debt to Assets

CASI Pharmaceuticals Cash Flow

CASI Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis